131 results on '"Hirsch, Irl B"'
Search Results
2. Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes
3. Continuous Glucose Monitoring: A Rapidly Evolving New Tool to Understand Pathophysiology and Enhance Clinical Care in CKD
4. Real‐time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta‐analysis
5. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial
6. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
7. Anti–PD-1 and Anti–PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes
8. Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research
9. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
10. Costs Associated With Using Different Insulin Preparations
11. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
12. Response to Comment on Wong et al. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37: 2702–2709
13. Lowering targets for hemoglobin A1c in children with type 1 diabetes: raising the bar
14. Diabetic Kidney Disease: A Report From an ADA Consensus Conference
15. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry
16. Interference of Intravenous Vitamin C With Blood Glucose Testing
17. Recommend Adding a DPP-4 Inhibitor to Metformin Therapy
18. Recommend Adding a DPP-4 Inhibitor to Metformin Therapy
19. Glycemic Management in a Patient with Type 2 Diabetes
20. Improvements in Our Understanding of Diabetes Mellitus
21. Hypoglycemia in Adults With Cystic Fibrosis During Oral Glucose Tolerance Testing
22. HIGH TITERS OF AUTOANTIBODIES TO GLUTAMATE DECARBOXYLASE IN TYPE 1 DIABETES PATIENTS: EPITOPE ANALYSIS AND INHIBITION OF ENZYME ACTIVITY
23. Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants
24. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS’ COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2013 CONSENSUS STATEMENT - EXECUTIVE SUMMARY
25. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTSʼ COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2013 CONSENSUS STATEMENT
26. Understanding Low Sugar from NICE-SUGAR
27. Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial
28. Understanding Low Sugar from NICE-SUGAR
29. Insulin-Pump Therapy for Type 1 Diabetes Mellitus
30. INSULIN GLARGINE OR NEUTRAL PROTAMINE HAGEDORN IN PATIENTS WITH SEVERE INSULIN RESISTANCE: IS THERE A BENEFIT?
31. Treatment of LADA With Etanercept
32. Self-monitoring of blood glucose
33. MOTHERHOOD, APPLE PIE, HEMOGLOBIN A1c, AND THE DCCT
34. PATIENT FACTORS ASSOCIATED WITH GLUCAGONLIKE PEPTIDE 1 RECEPTOR AGONIST USE WITH AND WITHOUT INSULIN
35. Metrics for Monitoring Glycemic Control—Reply
36. Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
37. Reexamining Metrics for Glucose Control
38. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN: EXECUTIVE SUMMARY
39. WHO WILL MANAGE AMERICAN PATIENTS WITH DIABETES? RESIDENTSʼ CAREER PREFERENCES AND PERCEPTIONS OF DIABETES CARE
40. AACE Task Force for Developing a Diabetes Comprehensive Care Plan Writing Committee
41. Home Blood Glucose Monitoring in Type 2 Diabetes: Broken health care system undermines studyʼs impact
42. How to proceed with glucose monitoring accuracy? An issue that requires immediate attention
43. In Response
44. Targeting β-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus
45. Practical Management of Hyperglycemia in the Noncritically Ill Medical/Surgical Patient
46. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS CONTINUOUS GLUCOSE MONITORING TASK FORCE
47. Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications
48. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin
49. Individualizing Care for the Many: The Evolving Role of Professional Continuous Glucose Monitoring Systems in Clinical Practice
50. Realistic Expectations and Practical Use of Continuous Glucose Monitoring for the Endocrinologist
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.